Takeda Pharmaceutical Co Ltd (NYSE:TAK)

17.01
Delayed Data
As of Apr 13
 +0.005 / +0.03%
Today’s Change
15.30
Today|||52-Week Range
20.00
-6.57%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$54.0B

Company Description

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Contact Information

Takeda Pharmaceutical Co., Ltd.
4-1-1 Dosho-machi
Osaka Osaka 540-8645
P:(166) 204-2111
Investor Relations:

Employees

Shareholders

Other institutional2.48%
Mutual fund holders1.01%
Individual stakeholders--

Top Executives

Christophe WeberPresident, CEO & Representative Director
Constantine SaroukosChief Financial Officer & Director
Andrew S. PlumpDirector, Research & Development President
Michael E. MendelsohnChief Medical & Scientific Officer
Mwana LugogoChief Ethics & Compliance Officer